Skip to main content

Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials

Heart Failure Reviews volume 26, pages 127–136 (2021)Cite this article

Abstract

Diuretics have an essential role in the management of heart failure (HF). However, each drug has its own benefit and side effect. Side effects include fluid, electrolyte abnormalities, and acid-base disturbance. These adverse effects of diuretics predispose patients to serious cardiac arrhythmias and may increase the risk of arrhythmic mortality. Herein, we aim to summarize the relative efficacy and safety of all available diuretics used in the treatment of patients with HF. In June 2017, a systematic electronic database search was conducted in nine databases. All randomized controlled trials (RCTs) comparing the different diuretics used in HF were included for meta-analysis. The protocol was registered in Prospero with CRD42018084819. Among the included 54 studies (10,740 patients), 34 RCTs were eligible for quantitative network meta-analysis (NMA) and traditional meta-analysis while the other 20 studies were qualitatively analyzed. Our results showed that azosemide and torasemide caused a significant reduction in brain natriuretic peptide (BNP) level. Torasemide also caused a significant decrease in collagen volume fraction (CVF) and edema. No significant difference between the agents concerning glomerular filtration rate (GFR), water extraction, and sodium excretion was demonstrated. Regarding side effects, no significant difference among diuretics was observed in terms of hospital readmission and mortality rates. Diuretics are the main treatment of hypervolemia in HF patients. The choice of appropriate diuretic is essential for successful management and is mainly guided by patient clinical situations and the presence of other co-morbidities.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

Data availability

All the study data and material are available.

References

  1. Kemp CD, Conte JV (2012) The pathophysiology of heart failure. Cardiovasc Pathol 21(5):365–371

    CAS  PubMed  Google Scholar 

  2. Buggey J, Mentz RJ, Pitt B, Eisenstein EL, Anstrom KJ, Velazquez EJ, O'Connor CM (2015) A reappraisal of loop diuretic choice in heart failure patients. Am Heart J 169(3):323–333

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire D, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2014) Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 129(3):e28–e292

  4. Chen HH, Schrier RW (2006) Pathophysiology of volume overload in acute heart failure syndromes. Am J Med 119(12 Suppl 1):S11–S16

    CAS  PubMed  Google Scholar 

  5. Miyata M, Sasaki T, Ikeda Y, Shinsato T, Kubozono T, Furusho Y, Kusumoto A, Hamasaki S, Tei C (2012) Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF). J Cardiol 59(3):352–358

    PubMed  Google Scholar 

  6. Hisatake S, Nanjo S, Fujimoto S, Yamashina S, Yuzawa H, Namiki A, Nakano H, Yamazaki J (2011) Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy. Eur J Heart Fail 13(8):892–898

    CAS  PubMed  Google Scholar 

  7. Matsuo Y, Kasama S, Toyama T, Funada R, Takama N, Koitabashi N, Ichikawa S, Suzuki Y, Matsumoto N, Sato Y, Kurabayashi M (2016) Comparative effects of long-acting and short-acting loop diuretics on cardiac sympathetic nerve activity in patients with chronic heart failure. Open Heart 3(1):e000276

    PubMed  PubMed Central  Google Scholar 

  8. Felker GM, Mentz RJ (2012) Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol 59(24):2145–2153

    CAS  PubMed  Google Scholar 

  9. Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, Maggioni AP, Cook T, Swedberg K, Burnett JC, Grinfeld L, Udelson JE, Zannad F, Gheorghiade M, on behalf of the EVEREST trial investigators (2013) Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 34(11):835–843

    PubMed  Google Scholar 

  10. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj. 339:b2700

    PubMed  PubMed Central  Google Scholar 

  11. Lopez B, Gonzalez A, Beaumont J, Querejeta R, Larman M, Diez J (2007) Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure. J Am Coll Cardiol 50(9):859–867

    CAS  PubMed  Google Scholar 

  12. Lopez B, Querejeta R, Gonzalez A, Beaumont J, Larman M, Diez J (2009) Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure. Hypertension. 53(2):236–242

    CAS  PubMed  Google Scholar 

  13. Lopez B, Querejeta R, Gonzalez A, Sanchez E, Larman M, Diez J (2004) Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 43(11):2028–2035

    CAS  PubMed  Google Scholar 

  14. Vetter TR, Mascha EJ (2017) Defining the primary outcomes and justifying secondary outcomes of a study: usually, the fewer, the better. Anesth Analg 125(2):678–681

    PubMed  Google Scholar 

  15. Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Bmj. 343:d5928

    PubMed  PubMed Central  Google Scholar 

  16. Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13

    PubMed  PubMed Central  Google Scholar 

  17. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj. 327(7414):557–560

    PubMed  PubMed Central  Google Scholar 

  18. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics. 50(4):1088–1101

    CAS  PubMed  Google Scholar 

  19. Sue D, Richard T (2000) Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 56(2):455–463

    Google Scholar 

  20. Stroobandt R, Dodion L, Kesteloot H (1982) Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide. Archives internationales de pharmacodynamie et de therapie 260(1):151–158

    CAS  PubMed  Google Scholar 

  21. Mentz RJ, Hasselblad V, DeVore AD et al (2016) Torsemide versus furosemide in patients with acute heart failure (from the ASCEND-HF trial). Am J Cardiol 117(3):404–411

    CAS  PubMed  Google Scholar 

  22. Olesen KH (1970) A comparison of the diuretic action of mercaptomerin, ethacrynic acid and furosemide in congestive heart failure. Acta Med Scand 187(5):391–399

    CAS  PubMed  Google Scholar 

  23. Abrams J (1981) Intramuscular bumetanide and furosemide in congestive heart failure. J Clin Pharmacol 21(11–12 Pt 2):673–679

    CAS  PubMed  Google Scholar 

  24. Marsh JD, Nesto R, Glynn MA, Smith TW (1982) Comparison of intravenous piretanide and furosemide in patients with congestive heart failure. J Cardiovasc Pharmacol 4(6):949–954

    CAS  PubMed  Google Scholar 

  25. Hariman RJ, Bremner S, Louie EK, Rogers WJ, Kostis JB, Nocero MA, Jones JP (1994) Dose-response study of intravenous torsemide in congestive heart failure. Am Heart J 128(2):352–357

    CAS  PubMed  Google Scholar 

  26. Paterna S, Fasullo S, Di Pasquale P (2005) High-dose torasemide is equivalent to high-dose furosemide with hypertonic saline in the treatment of refractory congestive heart failure. Clin Drug Investig 25(3):165–173

    CAS  PubMed  Google Scholar 

  27. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC (1995) Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 57(6):601–609

    CAS  PubMed  Google Scholar 

  28. Stewart JH, Edwards KD (1965) Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid. Br Med J 2(5473):1277–1281

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Fukui M, Tsujino T, Hirotani S, Ito H, Yamamoto K, Akasaka T, Hirano Y, Ohte N, Daimon T, Nakatani S, Kawabata M, Masuyama T (2017) Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis. Heart Vessel 32(7):865–871

    Google Scholar 

  30. Asami M, Aoki J, Tanimoto S, Horiuchi Y, Watanabe M, Furui K, Yasuhara K, Sato T, Tanabe K, Hara K (2017) Effects of long-acting loop diuretics in heart failure with reduced ejection fraction patients with cardiac resynchronization therapy. Int Heart J 58(2):211–219

    CAS  PubMed  Google Scholar 

  31. Scheen AJ, Vancrombreucq JC, Delarge J, Luyckx AS (1986) Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study. Eur J Clin Pharmacol 31(Suppl):35–42

    PubMed  Google Scholar 

  32. Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M (2006) Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure. Heart 92(10):1434–1440

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Masuyama T, Tsujino T, Origasa H, Yamamoto K, Akasaka T, Hirano Y, Ohte N, Daimon T, Nakatani S, Ito H (2012) Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure. Circulation journal : official journal of the Japanese Circulation Society 76(4):833–842

    CAS  Google Scholar 

  34. LM Pothuizen RC. (1982) Treatment of congestive cardiac failure in elderly patients randomised study of hydrochlorothiazide and slow-release furosemide. Curr Ther Res 32(4):513–519

    Google Scholar 

  35. (2011) Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study. Clinical therapeutics 33(9):1204–1213.e1203

  36. Pehrsson SK (1985) Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure. Eur J Clin Pharmacol 28(3):235–239

    CAS  PubMed  Google Scholar 

  37. Muller K, Gamba G, Jaquet F, Hess B (2003) Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life. Eur J Heart Fail 5(6):793–801

    CAS  PubMed  Google Scholar 

  38. Goebel KM (1993) Six-week study of torsemide in patients with congestive heart failure. Clin Ther 15(6):1051–1059

    CAS  PubMed  Google Scholar 

  39. Levy B (1977) The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure. J Clin Pharmacol 17(7):420–430

    CAS  PubMed  Google Scholar 

  40. Sigurd B, Leth A, Steiness E (1973) Bumetanide. A comparison between the diuretic effect of bumetanide and furosemide in patients with chronic congestive heart failure. Ugeskr Laeger 135(9):466–471

    CAS  PubMed  Google Scholar 

  41. Chaudhury RR, Chugh KS, Gupta GS, Sodhi P, Gupta KK (1968) A controlled clinical trial comparing the diuretic furosemide and hydrochlorothiazide. J Assoc Physicians India 16(2):157–163

    CAS  PubMed  Google Scholar 

  42. Ferrara N, Leosco D, Del Prete M et al (1997) Torasemide versus furosemide in patients with congestive heart failure: a double-masked, randomized study. Curr Ther Res 58(5):291–299

    CAS  Google Scholar 

  43. Michalsen H, Stokkeland M, Ditlefsen EM, Sangvik K (1976) Bumetanide (Burinex) --furosemide (Lasix). A comparative study in congestive heart failure. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 96(27):1428–1429

    CAS  Google Scholar 

  44. Hamdy RC, Vinson ME, Robbins AD, Struthers LPL, Chapman SF, Norris RS, Shaw HL (1984) Urinary electrolyte excretion after frusemide, amiloride and a combination of these drugs: an open, crossover study. Curr Med Res Opin 9(2):124–131

    CAS  PubMed  Google Scholar 

  45. Tomiyama H, Nakayama T, Watanabe G, Shiojima K, Sakuma Y, Yamamoto A, Imai Y, Yoshida H, Doba N (1999) Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure. Am Heart J 137(3):543–548

    CAS  PubMed  Google Scholar 

  46. Ogino K, Kinugasa Y, Kato M, Yamamoto K, Hisatome I, Anker SD, Doehner W (2014) Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure. Int J Cardiol 171(3):398–403

    PubMed  Google Scholar 

  47. (2002) Which loop diuretic for heart failure? For prognosis the choices are not all the same. MMW Fortschritte der Medizin 144(40):50

  48. Bonaduce D, Ferrara N, Canonico V Xipamide treatment in congestive heart failure: double-blind trial with furosemide. 311982

  49. Car N, Skrabalo Z, Verho M (1988) The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide. Curr Med Res Opin 11(2):133–141

    CAS  PubMed  Google Scholar 

  50. Chen ZH, Jiang YR, Peng JQ et al (2016) Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients. Experimental and therapeutic medicine 11(3):890–894

    CAS  PubMed  Google Scholar 

  51. Coodley EL, Nandi PS, Chiotellis P (1979) Evaluation of a new diuretic, diapamide, in congestive heart failure. J Clin Pharmacol 19(2–3):127–136

    CAS  PubMed  Google Scholar 

  52. Murray MD, Deer MM, Ferguson JA, Dexter PR, Bennett SJ, Perkins SM, Smith FE, Lane KA, Adams LD, Tierney WM, Brater DC (2001) Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 111(7):513–520

    CAS  PubMed  Google Scholar 

  53. Noe LL, Vreeland MG, Pezzella SM, Trotter JP (1999) A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure. Clin Ther 21(5):854–866

    CAS  PubMed  Google Scholar 

  54. Konecke LL (1981) Clinical trial of bumetanide versus furosemide in patients with congestive heart failure. J Clin Pharmacol 21(11–12 Pt 2):688–690

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Thanks to Tran Thai Huu Loc, Ahmed Bendary, and Thanh Nguyen for their help in the early stages of the study.

Code availability

All used software applications and codes are available.

Funding

This study was conducted (in part) at the Joint Usage/Research Center on Tropical Disease, Institute of Tropical Medicine, Nagasaki University, Japan.

Author information

Author notes

  1. Peter Samuel Eid, Doaa Alaa Ibrahim and Ahmad Helmy Zayan contributed equally to this work.

Authors and Affiliations

  1. Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Peter Samuel Eid, Doaa Alaa Ibrahim & Manal Mahmoud Abd Elrahman

  2. Online research Club (http://www.onlineresearchclub.org/), Nagasaki, Japan

    Peter Samuel Eid, Doaa Alaa Ibrahim, Ahmad Helmy Zayan, Manal Mahmoud Abd Elrahman, Mostafa Ahmed Abdo Shehata, Hend Kandil, Mahmoud Ahmed Abouibrahim, Luc Minh Duy, Ashraf Shinkar, Muhammed Khaled Elfaituri, Le Huu Nhat Minh, Mostafa Mahmoud Fahmy, Dao Ngoc Hien Tam, Nguyen Lam Vuong & Jaffer Shah

  3. Menoufia University, Menoufia, Egypt

    Ahmad Helmy Zayan

  4. Faculty of Medicine, Alexandria University, Alexandria, Egypt

    Mostafa Ahmed Abdo Shehata

  5. Faculty of Medicine, Menoufia University, Menoufia, Egypt

    Hend Kandil

  6. Faculty of Medicine, Cairo University, Cairo, Egypt

    Mahmoud Ahmed Abouibrahim

  7. Pham Ngoc Thach University of Medicine, Ho Chi Minh, 700000, Vietnam

    Luc Minh Duy

  8. Psychiatry Department, Ain Shams University, Cairo, Egypt

    Ashraf Shinkar

  9. Faculty of Medicine, University of Tripoli, Tripoli, Libya

    Muhammed Khaled Elfaituri

  10. University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam

    Le Huu Nhat Minh & Nguyen Lam Vuong

  11. Faculty of Medicine, Tanta University, Tanta, Egypt

    Mostafa Mahmoud Fahmy

  12. Nanogen Pharmaceutical Biotechnology Joint Stock Company, Ho Chi Minh city, 700000, Vietnam

    Dao Ngoc Hien Tam

  13. Drexel University College of Medicine, Philadelphia, PA, USA

    Jaffer Shah

  14. Tam Duc Cardiology Hospital, Ho Chi Minh City, Vietnam

    Van Buu Dan Do

  15. Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN), Leading Graduate School Program, and Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan

    Kenji Hirayama

  16. Institute of Research and Development, Duy Tan University, Da Nang, 550000, Vietnam

    Nguyen Tien Huy

Authors
  1. Peter Samuel Eid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Doaa Alaa Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmad Helmy Zayan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Manal Mahmoud Abd Elrahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mostafa Ahmed Abdo Shehata
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hend Kandil
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mahmoud Ahmed Abouibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Luc Minh Duy
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ashraf Shinkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Muhammed Khaled Elfaituri
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Le Huu Nhat Minh
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Mostafa Mahmoud Fahmy
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Dao Ngoc Hien Tam
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Nguyen Lam Vuong
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jaffer Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Van Buu Dan Do
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Kenji Hirayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Nguyen Tien Huy
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

PSE and NTH proposed the idea and designed the study. All authors participate in searching data bases, screening, data extraction, manuscript revision, and approved the final version of manuscript. PSE, NLV, NTH, and AHZ performed the descriptive analysis and wrote the manuscript.

Corresponding author

Correspondence to Nguyen Tien Huy.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 384 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Eid, P.S., Ibrahim, D.A., Zayan, A.H. et al. Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials. Heart Fail Rev 26, 127–136 (2021). https://doi.org/10.1007/s10741-020-10003-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-020-10003-7

Keywords

  • Heart failure
  • Diuretics
  • Furosemide
  • Heart dysfunction
  • Myocardial failure